1Pang R, He DN, Zhou B, et al. In vitro inhibition of Japanese encephalitis virus replication by capsid-targeted virus inactivation [J]. Antiviral Res,2013,97(3) : 369-375.
2Wang Q, Weng L, Tian X, et al. Effect of the methyhransferase domain of Japanese encephalitis virus NS5 on the polymerase activ- ity[J]. Biochim Biophys Acta,2012,1819(5) :411-8.
3Mackenzie JS, Gubler D J, Petersen LR. et al. Emerging flavivir-uses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses [ J ]. Nat Med,2004,10 ( 12 Suppl) : $9 - 109.
6Trent DW, Minor P, Jivapaisampong T, et al. WHO working group on the quality, safety and efficacy of japanese encephalitis vaccines ( live attenuated) for human use, Bangkok, Thailand, 21-23 February 2012[J]. Biologieals,2013,41 (6) :450-457.
7Solomon T. Control of Japanese encephalitis--within our grasp? [J]. N Engl J Med,2006,355(9) :869-871.
8Halstead SB, Thomas SJ. New Japanese encephalitis vaccines: alternatives to production in mouse brain [ J ]. Expert Rev Vac- cines.2011.10(3) :355-364.
